Outcomes of patients who stopped immunotherapy due to immune-related side effects
Immunotherapy has changed the way advanced renal cell carcinoma (RCC) [...]
ASCO 2020: Factors influencing outcomes in kidney cancer treated with immunotherapy
A study presented during the 2020 American Society of Clinical [...]
ASCO GU 2020: Adding radiotherapy to immunotherapy for the treatment of metastatic kidney cancer
Two clinical trials looking at the use of radiotherapy and [...]
Ilixadencel improves responses and survival in metastatic kidney cancer
Results from a recent phase 2 clinical trial of ilixadencel [...]
Scientists discover a part of the immune system that may be used to treat all cancers
Scientists from the University of Cardiff have discovered part of [...]
Rational approaches to treatment duration with immunotherapy for kidney cancer
A recent review of the use of immune checkpoint inhibitors [...]
Assessing and managing adverse events to immunotherapies
In this video interview, Brenda Martone discusses the clinical nurse [...]
Nivolumab/ipilimumab combination extends treatment-free survival in kidney cancer patients
Immune checkpoint inhibitors (ICIs), such as nivolumab and ipilimumab have [...]
Cytoreductive nephrectomy offers survival benefit in metastatic kidney cancer
The results of a trial looking at immunotherapy treatment with [...]
IKCS 2019: Immune related adverse events
Dr Mehmet Asim Bilen of Emory University School of Medicine [...]
